Assessing emerging wastewater regulations to minimize the risk from pharmaceuticals and personal care products

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Management of Environmental Quality: An International Journal

• Publication date

  2015-08-17

• Fields of study

  Engineering, Environmental Science

• Identifiers
  DOI 10.1108/MEQ-12-2014-0171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• What have we learned from worldwide experiences on the management and treatment of hospital effluent? — An overview and a discussion on perspectives

  2015cited by this paper
• Evaluating the degradation, sorption, and negative mass balances of pharmaceuticals and personal care products during wastewater treatment.

  2015cited by this paper
• A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment.

  2014cited by this paper
• International scientists' priorities for research on pharmaceutical and personal care products in the environment

  2014cited by this paper
• Lower-dose prescribing: minimizing "side effects" of pharmaceuticals on society and the environment.

  2013cited by this paper
• Economic valuation of environmental benefits of removing pharmaceutical and personal care products from WWTP effluents by ozonation.

  2013cited by this paper
• Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern.

  2013cited by this paper
• Removal of pharmaceuticals from a WWTP secondary effluent by ultrafiltration/reverse osmosis followed by electrochemical oxidation of the RO concentrate

  2013cited by this paper
• Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants.

  2013cited by this paper
• Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewater.

  2013cited by this paper
• Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review.

  2013cited by this paper
• Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy.

  2012cited by this paper
• Life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals.

  2012cited by this paper
• Influence of biofouling on pharmaceuticals rejection in NF membrane filtration.

  2012cited by this paper
• Response to "comment on life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals"

  2012cited by this paper
• Seeking a compromise between pharmaceutical pollution and phosphorus load: Management strategies for Lake Tegel, Berlin.

  2012cited by this paper
• Evaluation of Actiflo® Carb Process for the Combined Removal of Trace Organic Compounds and Phosphorous during Wastewater Tertiary Treatment

  2012cited by this paper
• Membrane bioreactor and nanofiltration hybrid system for reclamation of municipal wastewater: removal of nutrients, organic matter and micropollutants.

  2012cited by this paper
• Comment on "life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals".

  2012cited by this paper
• Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review.

  2012cited by this paper
• Green pharmacy and pharmEcovigilance: prescribing and the planet

  2011cited by this paper
• Indicator compounds for assessment of wastewater effluent contributions to flow and water quality.

  2011cited by this paper
• Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy.

  2011cited by this paper
• Xenobiotic removal efficiencies in wastewater treatment plants: residence time distributions as a guiding principle for sampling strategies.

  2011cited by this paper
• Active heterotrophic biomass and sludge retention time (SRT) as determining factors for biodegradation kinetics of pharmaceuticals in activated sludge.

  2011cited by this paper
• Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.

  2010cited by this paper
• Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management.

  2010cited by this paper
• The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.

  2009cited by this paper
• Disposal practices for unwanted residential medications in the United States.

  2009cited by this paper
• Actor modelling and its contribution to the development of integrative strategies for management of pharmaceuticals in drinking water.

  2009cited by this paper
• Pharmaceuticals in wastewater: behavior, preferences, and willingness to pay for a disposal program.

  2009cited by this paper
• Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids.

  2008cited by this paper
• Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage.

  2008cited by this paper
• Charting a path for innovative toilet technology using multicriteria decision analysis.

  2008cited by this paper
• Weighing environmental advantages and disadvantages of advanced wastewater treatment of micro-pollutants using environmental life cycle assessment.

  2008cited by this paper
• Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.

  2007cited by this paper
• Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry.

  2007cited by this paper
• Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals

  2007cited by this paper
• Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments.

  2006cited by this paper
• Performance and cost estimation of nanofiltration for surface water treatment in drinking water production

  2006cited by this paper
• Effect of membrane fouling on transport of organic contaminants in NF/RO membrane applications

  2006cited by this paper
• Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids.

  2005cited by this paper
• Factors affecting the rejection of organic solutes during NF/RO treatment--a literature review.

  2004cited by this paper
• Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions.

  2002cited by this paper
• Harmful algal blooms and eutrophication: Nutrient sources, composition, and consequences

  2002cited by this paper
• Microfiltration of Municipal Wastewater for Disinfection and Advanced Phosphorus Removal: Results from Trials with Different Small‐Scale Pilot Plants

  2000cited by this paper
• Better Bootstrap Confidence Intervals

  1987cited by this paper

• U.S. News Media Coverage of Pharmaceutical Pollution in the Aquatic Environment: A Content Analysis of the Problems and Solutions Presented by Actors

  2017cites this paper
• Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review

  2016cites this paper